Inventor

COFFEN DAVID L

US26 patents

⚠️ This page may combine multiple inventors who share the name “COFFEN DAVID L”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

COFFEN DAVID L

HOFFMANN LA ROCHE

Production of benzopyran-2-carboxylic acids and esters by enzymatic hydrolysis

Glycidic acid ester and process of preparation

Production of 2-hydroxy substituted arylalkanoic acids and esters by enzymatic hydrolysis

Vitamin E intermediate

Vitamin E intermediates

2-(trimethyl-tridecenyl)-tetramethylchroman intermediates for vitamin E

Process for bicyclic diketones

Cyclopenta[b]furan-2-ones

Preparation of diketones

Novel 4-phenoxy-5-sulfamylbenzoic acid

Lower-alkyl or aryl-sulfonyl unsaturated tacopherols

Prostaglandin intermediates

Prostaglandin intermediates

GIVAUDAN CORP

Preservation of aqueous systems with α-bromo-β-aminocrotononitrile

Preservation of aqueous systems with α-halo-β-aminocrotonic acid esters

Preservation of aqueous systems with 2-chloro-3-oxobutyramide derivatives

Preservation of aqueous systems with 2-chloro-3-oxobutyramide derivatives

Preservation of aqueous systems with α-chloro-β-aminocrotonamide

ARQULE INC

Synthesis and use of α-ketoamide derivatives and arrays

Synthesis and use of α-ketoamide derivatives and arrays

Spiro[pyrrolidine-2,3&#39;-oxindole] compounds and methods of use

Spiro[pyrrolidine-2,3′-oxindole] compounds and method of use

PROTEOTECH INC

Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer&#39;s disease, type 2 diabetes, and parkinson&#39;s disease

Compounds, compositions and methods for the treatment of amyloid diseases such as systemic AA amyloidosis

SNOW ALAN D

Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as Alzheimer&#39;s disease, type 2 diabetes and Parkinson&#39;s disease

Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer&#39;s disease, type 2 diabetes and parkinson&#39;s disease

Spiro[pyrrolidine-2,3'-oxindole] compounds and methods of use

Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes, and parkinson's disease

Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as Alzheimer's disease, type 2 diabetes and Parkinson's disease

Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes and parkinson's disease